Drug Profile
Glibenclamide/metformin
Alternative Names: Glucovance; Glyburide/metformin; Metformin/glibenclamide; Metformin/glyburideLatest Information Update: 05 Nov 2023
Price :
$50
*
At a glance
- Originator Merck Sante
- Class Antihyperglycaemics; Biguanides; Small molecules; Sulfonylureas
- Mechanism of Action AMP activated protein kinase stimulants; KATP channel inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Marketed Type 2 diabetes mellitus